6-87155652-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_015021.3(ZNF292):c.61G>A(p.Glu21Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00000769 in 1,430,782 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000077 ( 0 hom. )
Consequence
ZNF292
NM_015021.3 missense
NM_015021.3 missense
Scores
4
7
8
Clinical Significance
Conservation
PhyloP100: 4.70
Genes affected
ZNF292 (HGNC:18410): (zinc finger protein 292) This gene encodes a growth hormone-dependent, zinc finger transcription factor that functions as a tumor suppressor. Naturally occurring mutations in this gene are associated with gastric cancer, colorectal cancer, and chronic lymphocytic leukemia. [provided by RefSeq, May 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.34573093).
BS2
High AC in GnomAdExome4 at 11 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF292 | NM_015021.3 | c.61G>A | p.Glu21Lys | missense_variant | 1/8 | ENST00000369577.8 | NP_055836.1 | |
ZNF292 | NM_001351444.2 | c.-505G>A | 5_prime_UTR_variant | 1/9 | NP_001338373.1 | |||
ZNF292 | XM_047418459.1 | c.-673G>A | 5_prime_UTR_variant | 1/10 | XP_047274415.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF292 | ENST00000369577.8 | c.61G>A | p.Glu21Lys | missense_variant | 1/8 | 1 | NM_015021.3 | ENSP00000358590.3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome AF: 0.00000769 AC: 11AN: 1430782Hom.: 0 Cov.: 31 AF XY: 0.00000564 AC XY: 4AN XY: 708786
GnomAD4 exome
AF:
AC:
11
AN:
1430782
Hom.:
Cov.:
31
AF XY:
AC XY:
4
AN XY:
708786
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Intellectual developmental disorder, autosomal dominant 64 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Pittsburgh Clinical Genomics Laboratory, University of Pittsburgh Medical Center | Jun 04, 2024 | This sequence variant is a single nucleotide substitution (G>A) at position 61 of the coding sequence of the ZNF292 gene that results in a glutamic acid to lysine amino acid change at residue 21 of zinc finger protein 292. This variant is present in 11 of 1583162 alleles (0.00078%) in the gnomAD v4.1.0 population dataset and has not been observed in individuals affected by ZNF292-related conditions in the published literature, to our knowledge. Multiple bioinformatic tools provide conflicting predictions concerning the impact of this amino acid change, and the Glu21 residue at this position is highly conserved across the vertebrate species examined. Studies examining the functional consequence of this variant have not been published, to our knowledge. At this time, there is insufficient evidence to determine if this variant is pathogenic or benign. Therefore, we consider this a variant of uncertain significance. ACMG Criteria: PM2, PM5 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;T;T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;.;.
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;N;N;N
REVEL
Benign
Sift
Pathogenic
D;D;D;D
Sift4G
Pathogenic
D;T;D;T
Polyphen
0.82
.;P;.;.
Vest4
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at